|
Thrombolysis
Citations 141-150 of 180 total displayed.
|
Past content
(since Mar 1998):
|
- Original Investigations
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
- James D. Douketis; Gary A. Foster; Mark A. Crowther; Martin H. Prins; Jeffrey S. Ginsberg
Arch Intern Med 2000; 160: 3431-3436.
[Abstract]
[Full text]
[PDF]
- Review Articles
An Overview of Acute Stroke Therapy: Past, Present, and Future
- Marc Fisher; Wolf Schaebitz
Arch Intern Med 2000; 160: 3196-3206.
[Extract]
[Full text]
[PDF]
- Original Investigations
Cost for Inpatient Care of Venous Thrombosis: A Trial of Enoxaparin vs Standard Heparin
- Gregory de Lissovoy; Roger D. Yusen; Theodore E. Spiro; William C. Krupski; Annette H. Champion; Sonja V. Sorensen
Arch Intern Med 2000; 160: 3160-3165.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Effectiveness and Economic Impact Associated With a Program for Outpatient Management of Acute Deep Vein Thrombosis in a Group Model Health Maintenance Organization
- Donald J. Tillman; Scott L. Charland; Daniel M. Witt
Arch Intern Med 2000; 160: 2926-2932.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Minimum Effective Intensity of Oral Anticoagulant Therapy in Primary Prevention of Coronary Heart Disease
- Peter K. MacCallum; Patrick J. Brennan; Thomas W. Meade; for the Medical Research Council's General Practice Research Framework
Arch Intern Med 2000; 160: 2462-2468.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery: A Meta-analysis
- Alfonso Iorio; Giancarlo Agnelli
Arch Intern Med 2000; 160: 2327-2332.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Frequency of Major Hemorrhage in Patients Treated With Unfractionated Intravenous Heparin for Deep Venous Thrombosis or Pulmonary Embolism: A Study in Routine Clinical Practice
- Majida Zidane; Miranda T. Schram; Erwin W. Planken; Wim H. Molendijk; Frits R. Rosendaal; Felix J. M. van der Meer; Menno V. Huisman
Arch Intern Med 2000; 160: 2369-2373.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients: A Double-blind, Randomized Comparison
- Russell D. Hull; Graham F. Pineo; Charles Francis; David Bergqvist; Carin Fellenius; Karin Soderberg; Anna Holmqvist; Michael Mant; Richard Dear; Barry Baylis; Andrew Mah; Rollin Brant; for the North American Fragmin Trial Investigators
Arch Intern Med 2000; 160: 2199-2207.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients: A Double-blind, Randomized Comparison
- Russell D. Hull; Graham F. Pineo; Charles Francis; David Bergqvist; Carin Fellenius; Karin Soderberg; Anna Holmqvist; Michael Mant; Richard Dear; Barry Baylis; Andrew Mah; Rollin Brant; for the North American Fragmin Trial Investigators
Arch Intern Med 2000; 160: 2208-2215.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Prophylactic Antithrombotic Therapy for Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies: Do the Benefits Outweigh the Risks? A Decision Analysis
- Denis G. Wahl; Henri Bounameaux; Philippe de Moerloose; François P. Sarasin
Arch Intern Med 2000; 160: 2042-2048.
[Abstract]
[Full text]
[PDF]
|
|
